Search research articles
Contact Us
Filters
Showing results (1-10 of 46) with videos related to
Page
of 5
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 2, 2000
In vivo imaging of the vesicular acetylcholine transporter and the vesicular monoamine transporter
S M Efange
Journal of Computer-Aided Molecular Design
|
October 1, 1991
Molecular determinants in the bioactivation of the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
S M Efange, R J Boudreau
Investigative Radiology
|
August 1, 1992
Computer-aided radiopharmaceutical design
R J Boudreau, S M Efange
Neuroreport
|
January 20, 1997
Vesicular acetylcholine transport inhibitor suppresses REM sleep
M L Capece, S M Efange, R Lydic
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 1, 1996
Age-related diminution of dopamine antagonist-stimulated vesamicol receptor binding
S M Efange, R B Langason, A B Khare
Nuclear Medicine and Biology
|
May 1, 1995
Comparative tissue distribution of conformationally restricted radioiodinated vesamicol receptor ligands
S M Efange, A B Khare, R B Langason
Journal of Medicinal Chemistry
|
November 7, 1998
Modified ibogaine fragments: synthesis and preliminary pharmacological characterization of 3-ethyl-5-phenyl-1,2,3,4,5, 6-hexahydroazepino[4,5-b]benzothiophenes
S M Efange, D C Mash, A B Khare, et al.
Journal of Medicinal Chemistry
|
May 1, 1988
Synthesis and biodistribution of 99mTc-labeled piperidinyl bis(aminoethanethiol) complexes: potential brain perfusion imaging agents for single photon emission computed tomography
S M Efange, H F Kung, J J Billings, et al.
Experimental Neurology
|
May 1, 1990
Potential environmental neurotoxins related to 1-methyl-4-phenylpyridinium: selective toxicity of 1-methyl-4-(4'-acetamidophenyl)-pyridinium and 1-methyl-4-cyclohexylpyridinium for dopaminergic neurons in culture
P P Michel, B K Dandapani, S M Efange, et al.
Journal of Cardiovascular Pharmacology
|
December 22, 1999
Direct cardiac effects of a novel vesamicol receptor ligand, m-iodobenzyl-trozamicol, assessed in the canine isolated, blood-perfused heart preparations
A Sugiyama, K G Lurie, S M Efange, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 46) with videos related to
Sort By:
Page
of 5
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 2, 2000
In vivo imaging of the vesicular acetylcholine transporter and the vesicular monoamine transporter
S M Efange
Journal of Computer-Aided Molecular Design
|
October 1, 1991
Molecular determinants in the bioactivation of the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
S M Efange, R J Boudreau
Investigative Radiology
|
August 1, 1992
Computer-aided radiopharmaceutical design
R J Boudreau, S M Efange
Neuroreport
|
January 20, 1997
Vesicular acetylcholine transport inhibitor suppresses REM sleep
M L Capece, S M Efange, R Lydic
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 1, 1996
Age-related diminution of dopamine antagonist-stimulated vesamicol receptor binding
S M Efange, R B Langason, A B Khare
Nuclear Medicine and Biology
|
May 1, 1995
Comparative tissue distribution of conformationally restricted radioiodinated vesamicol receptor ligands
S M Efange, A B Khare, R B Langason
Journal of Medicinal Chemistry
|
November 7, 1998
Modified ibogaine fragments: synthesis and preliminary pharmacological characterization of 3-ethyl-5-phenyl-1,2,3,4,5, 6-hexahydroazepino[4,5-b]benzothiophenes
S M Efange, D C Mash, A B Khare, et al.
Journal of Medicinal Chemistry
|
May 1, 1988
Synthesis and biodistribution of 99mTc-labeled piperidinyl bis(aminoethanethiol) complexes: potential brain perfusion imaging agents for single photon emission computed tomography
S M Efange, H F Kung, J J Billings, et al.
Experimental Neurology
|
May 1, 1990
Potential environmental neurotoxins related to 1-methyl-4-phenylpyridinium: selective toxicity of 1-methyl-4-(4'-acetamidophenyl)-pyridinium and 1-methyl-4-cyclohexylpyridinium for dopaminergic neurons in culture
P P Michel, B K Dandapani, S M Efange, et al.
Journal of Cardiovascular Pharmacology
|
December 22, 1999
Direct cardiac effects of a novel vesamicol receptor ligand, m-iodobenzyl-trozamicol, assessed in the canine isolated, blood-perfused heart preparations
A Sugiyama, K G Lurie, S M Efange, et al.
Page
of 5